Clinical Decision Support for Blood Transfusion Guidelines in Anemia

Recruiting in Palo Alto (17 mi)

Overseen byRyan Metcalf, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Utah

No Placebo Group

Trial Summary

What is the purpose of this trial?

Determine whether clinical decision support (best practice advisory) improves provider adherence to transfusion guidelines for all four major blood components (red blood cells, plasma, platelets, and cryoprecipitate) using a randomized study design to reduce risk of bias. Alerts will be visible to the experimental ordering provider group, while they will not be visible to the control. Both groups still have access to information about best practices: local clinical transfusion guidelines are available and education on blood transfusion best practices will continue regardless of randomization assignment.

Research Team

Ryan Metcalf, MD

Principal Investigator

University of Utah

Eligibility Criteria

This trial is for healthcare providers who have the authority to order at least one type of blood product in an electronic health record system. It's not open to individuals without privileges to place initial orders for blood products.

Inclusion Criteria

Ordering providers that order at least one blood product in the electronic health record

Exclusion Criteria

I cannot order blood products myself.

Treatment Details

Interventions

Clinical Decision Support (Behavioral)

Trial OverviewThe study tests if a 'clinical decision support' alert improves adherence to transfusion guidelines when ordering red cells, plasma, platelets, and cryoprecipitate. Providers are randomly assigned to either see these alerts or not while both groups continue receiving education on best practices.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Ordering Providers Assigned to Visible Clinical Decision Support AlertsExperimental Treatment1 Intervention

Clinical decision support alert will fire and become visible to the ordering provider in the electronic health record if blood product(s) are ordered out of accordance with guidelines. Information about transfusion guidelines and best practices will be sent to providers prior to starting the study and will be available on an internal website.

Group II: Ordering Providers Assigned to No Visible Clinical Decision Support AlertsActive Control1 Intervention

Clinical decision support alert will not be visible to the ordering provider in the electronic health record if blood product(s) are ordered out of accordance with guidelines. Information about transfusion guidelines and best practices will be sent to providers prior to starting the study and will be available on an internal website.